Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be made available from 2027 at around $40 a year in more than 100 low and middle-income countries, a move hailed as a potential gamechanger in the fight against the AIDS epidemic.
Related Posts
Uso de aparelhos auditivos reduz risco de demência, mostra estudo
Um novo estudo americano mostrou que o uso de aparelhos para o tratamento para perda auditiva é capaz de reduzir…
Portage la Prairie man charged with indecent acts after park exposure, RCMP say
RCMP in Portage la Prairie, Man., say a local man is facing charges after reports of an adult exposing himself…
Does buying an iPhone 17 on EMI impact your credit score? Here’s the truth
Buying an iPhone 17 on EMI can influence your credit score based on timely repayments, credit utilisation, and financial discipline,…